SeedFolio

Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors. These drugs directly stop tumor growth and selectively stop immunosuppression in the tumor without targeting the current immune checkpoint pathways. The company was founded in 2018 and is headquartered in San Diego, California.

Duo Oncology develops a new nanoparticle technology specially tailored to penetrate established tumors. Duo Oncology operates as a lean pharma business. The company works hand-in-hand with world-class university scientists and medical oncologists to develop their products through a network of established research organizations with the greatest possible speed and efficiency.

Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirects pre-existing pathogenic or childhood vaccine immune memory towards tumors.

Vecktais the Energy Transition Market Platform. Veckta integrates the world’s most advanced energy system engineering tools with an end-to-end marketplace to integrate and accelerate the development of distributed energy systems (DES) and microgrid projects. Veckta empowers businesses and communities to quickly and easily baseline their energy situation today, customize a solution specific to their needs (cost, reliability, and/or emissions), and then seamlessly engage and contract the best equipment, services, and capital providers in the market to finance, deploy and operate it sustainably and profitably.

Ordaōs is a human-enabled, machine-driven drug design company. We create customized mini-proteins that help pharma and biotechs around the world deliver safer and more effective life-saving treatments in a fraction of the time of traditional discovery methods. miniPRO proteins are created and evaluated in silico, and then rigorously tested in vitro, which enables us to reliably and repeatedly deliver de novo solutions that meet our client’s stringent requirements at scale, including novelty and probability of clinical success. At Ordaōs, we help birth novel therapies that reduce patient suffering, improve health, and extend life.

Developer of a miniature biosensing device intended to use a small blood volume to derive data on multiple biomarkers present in the sample.

Diseases of the neuromuscular junction have profound health effects including paralysis, breathing and swallowing difficulties. Amplo Biotechnology plans to develop multiple, potentially curative, Adeno-Associated Viral (AAV) therapies for the neuromuscular junction with an initial focus on congenital myasthenic syndromes. Amplo’s lead program, AAV-Dok7, was developed by Professor Yuji Yamanashi's group of the Institute of Medical Science at the University of Tokyo, and is applicable to multiple rare, severe diseases.

Labviva is a digital marketplace for life science products that connects researchers with reagents, chemicals, and instrumentation suppliers. It leverages the scientific context as the organizing principle, connecting researchers with suppliers in an intuitive user-friendly platform while making it easy for suppliers to provide and manage the content for their products. Labviva's Inventory Management System (IMS) offers real-time inventory tracking, AI-driven purchase automation, and forecasting, enhancing operational efficiency and compliance.

Deep Blue is developing a novel hernia mesh to address the unacceptably high rate of hernia occurrence and recurrence. Millions of hernia surgeries are done globally with billions of dollars in clinical cost. Their surgeon-invented mesh with integral suture-like extensions is designed to eliminate a key point of failure for conventional mesh fixation - the mesh, suture, tissue interface - and to provide superior anchor strength. In addition, Their Anchor Clip fixation device design enables faster, stronger, easier mesh implantation. Deep Blue products enhance hernia surgery with a potentially significant impact on the $1.1B global hernia device market. Due to its simple yet revolutionary design, the T-Line Mesh has the potential to reduce hernia occurrence and recurrence by preventing or reducing mesh fixation failure.

Inspirit is a virtual reality tool for science and STEM education. The company's virtual labs, simulations, and virtual reality are being used to transform science courses all over the world. They provide educational institutions with access to a next-generation learning platform that includes a large library of immersive labs and simulations that are available on a variety of desktop/laptop and VR platforms. Its platform includes tools for classroom management, custom assessment integrations, group or networked lab sessions, and curriculum alignment options. Inspirit was launched in 2019 and is based in Palo Alto, California.

Allotrope Medical is a Houston-based medical device company. Allotrope Medical’s first device, the StimSite, is an intuitive hand-held device that assists surgeons in quickly and easily identifying ureters during a surgical procedure.

Tiamat is a start-up producing affordable animal-free growth factors and biomolecules using plants as bioreactors. Thanks to its propriety platform, the company can manufacture a wide range of high-value proteins from antigens to growth factors. The company has already achieved a 10x cost reduction and at scale can get costs down 1000x even at 80% growth-margins, giving them a wide ability to price strategically. the coming years. The low investment needed to build a facility (up to 40x less than current solutions) combined with its unique technology makes Tiamat the ideal partner in production scale-up for promising markets that will soon become enormous such as cellular agriculture or cell & gene therapy.

Clinical Maestro™ by Strategikon Pharma is the only commercially available software platform for the end- to- end management of “clinical business operations”, which is the pharmaceutical industry vertical for planning, outsourcing and budgeting clinical trials. Biopharmaceutical companies outsource 90% of their clinical development pipeline spending billions of dollars engaging in highly complex outsourced relationships with thousands of global service providers, each using their own processes, systems and reporting structures. These sophisticated relationships require complex outsourcing strategies, demanding clinical financial planning, extensive sourcing due diligence and rigorous performance management. Currently the industry manages these activities in Excel, using labor intensive, inefficient processes, costing billions of dollars in infrastructure costs, regulatory non-compliance fines and delays to market. Clinical Maestro takes a radically different approach to the management of clinical portfolio through a transformative redesign of Excel-driven processes into end-to-end integrated workflows, breaking the communication and data integration siloes between pharma companies and their outsourcing partners. Clinical Maestro™ cases studies with leading pharmaceutical companies and CROs demonstrate savings of >80% vs. manual processes, >95% prediction accuracy for clinical study budgets and high user satisfaction and engagement.

Ready, Set, Food! makes it easy for parents reduce their baby's risk of developing peanut, egg, and milk allergies by up to 80% with our gentle, daily system.

Optimize Health is a provider of a digital healthcare platform that enables the deployment of Remote Patient Monitoring (RPM) programs. It uses easy-to-use equipment and software. The software is designed to facilitate provider compliance when billing to new Medicare CPT codes for RPM while providing a great user experience for both patients and providers. Its system is designed to be profitable for physicians starting in the first month.

Everest Labs is advancing the waste management industry using modern technologies such as Artificial Intelligence (AI), Machine Learning (ML), and Computer Vision and Robotics. The company's solutions increase the quality of marketable recyclables and reduces dependency on human labor while enabling top line and bottom line revenue growth for waste management companies.

Buzz Solutions provides a software platform powered by Artificial Intelligence, Actionable Insights, and Predictive Analytics for faults and anomaly detection for the power line inspection process for power utilities. The company's platform automates the process of storing and organizing visual data (captured in the field through drones and helicopters), analyzing for faults using its AI algorithms, mapping the data and providing heat maps as well as predictive insights for when, where and what kind of faults are happening on power line and assets. Using its solutions, power utilities save over 50% of cost and time to analyze data which makes condition-based maintenance efforts easier and time-efficient, thus, preventing wildfires, power outages, and other climate change effects on the physical infrastructure of the grid.

Chronus Health is a portable platform that enables doctors to provide real-time treatment based on actual lab results. The company developing a portable CLIA waived system to deliver point-of-care lab results in minutes. It allows for real-time diagnosis at the point-of-care providing lab results in minutes, dramatically improving patient outcomes. Chronus Health was founded in 2017 and is headquartered in Mountain View, California, United States.

AccessParks is a provider of outdoor internet that meets Broadband speeds. AccessParks provides park Wi-Fi that simply works, with no excuses; fully managed fiber optic-fed Broadband access, allowing 4,000+ devices to stream video simultaneously. AccessParks manages networks from the fiber to the devices used by guests. Every day, its 24/7 support and network operations center monitors and optimizes the network.